Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3150494735;94736;94737 chr2:178547015;178547014;178547013chr2:179411742;179411741;179411740
N2AB2986389812;89813;89814 chr2:178547015;178547014;178547013chr2:179411742;179411741;179411740
N2A2893687031;87032;87033 chr2:178547015;178547014;178547013chr2:179411742;179411741;179411740
N2B2243967540;67541;67542 chr2:178547015;178547014;178547013chr2:179411742;179411741;179411740
Novex-12256467915;67916;67917 chr2:178547015;178547014;178547013chr2:179411742;179411741;179411740
Novex-22263168116;68117;68118 chr2:178547015;178547014;178547013chr2:179411742;179411741;179411740
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Q
  • RefSeq wild type transcript codon: CAA
  • RefSeq wild type template codon: GTT
  • Domain: Fn3-117
  • Domain position: 97
  • Structural Position: 131
  • Q(SASA): 0.4707
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Q/P rs777578106 -0.042 0.991 N 0.493 0.234 0.27132560031 gnomAD-2.1.1 8.11E-06 None None None None N None 0 5.83E-05 None 0 0 None 0 None 0 0 0
Q/P rs777578106 -0.042 0.991 N 0.493 0.234 0.27132560031 gnomAD-4.0.0 3.208E-06 None None None None N None 0 4.59918E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Q/A 0.3685 ambiguous 0.3939 ambiguous -0.356 Destabilizing 0.855 D 0.339 neutral None None None None N
Q/C 0.6818 likely_pathogenic 0.708 pathogenic 0.264 Stabilizing 0.998 D 0.496 neutral None None None None N
Q/D 0.8845 likely_pathogenic 0.905 pathogenic -0.71 Destabilizing 0.978 D 0.421 neutral None None None None N
Q/E 0.1739 likely_benign 0.194 benign -0.704 Destabilizing 0.931 D 0.349 neutral N 0.436934854 None None N
Q/F 0.8434 likely_pathogenic 0.8763 pathogenic -0.451 Destabilizing 0.961 D 0.587 neutral None None None None N
Q/G 0.5309 ambiguous 0.5631 ambiguous -0.616 Destabilizing 0.978 D 0.487 neutral None None None None N
Q/H 0.489 ambiguous 0.5271 ambiguous -0.752 Destabilizing 0.991 D 0.315 neutral N 0.507376374 None None N
Q/I 0.4731 ambiguous 0.5208 ambiguous 0.263 Stabilizing 0.78 D 0.484 neutral None None None None N
Q/K 0.1681 likely_benign 0.1905 benign -0.158 Destabilizing 0.931 D 0.365 neutral N 0.403651786 None None N
Q/L 0.1984 likely_benign 0.221 benign 0.263 Stabilizing 0.002 N 0.152 neutral N 0.377025332 None None N
Q/M 0.4292 ambiguous 0.4596 ambiguous 0.843 Stabilizing 0.961 D 0.4 neutral None None None None N
Q/N 0.667 likely_pathogenic 0.7057 pathogenic -0.533 Destabilizing 0.978 D 0.403 neutral None None None None N
Q/P 0.9045 likely_pathogenic 0.9181 pathogenic 0.087 Stabilizing 0.991 D 0.493 neutral N 0.453387173 None None N
Q/R 0.1635 likely_benign 0.183 benign -0.007 Destabilizing 0.971 D 0.413 neutral N 0.353879114 None None N
Q/S 0.5141 ambiguous 0.5381 ambiguous -0.507 Destabilizing 0.978 D 0.315 neutral None None None None N
Q/T 0.3719 ambiguous 0.4058 ambiguous -0.34 Destabilizing 0.935 D 0.432 neutral None None None None N
Q/V 0.2783 likely_benign 0.2983 benign 0.087 Stabilizing 0.594 D 0.347 neutral None None None None N
Q/W 0.8081 likely_pathogenic 0.8571 pathogenic -0.406 Destabilizing 0.998 D 0.545 neutral None None None None N
Q/Y 0.7322 likely_pathogenic 0.7714 pathogenic -0.144 Destabilizing 0.994 D 0.505 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.